ASHPOfficial is the premier podcast of ASHP and the collective voice of our 50,000 members in health-system pharmacy. Through interviews and discussions with pharmacy thought leaders, ASHPOfficial will explore issues related to public health, medication use, and supporting the professional practice of pharmacists in hospitals, health systems, ambulatory clinics, and other settings. To learn more about ASHP, please visit ashp.org.
Episodes
Monday Nov 07, 2022
Monday Nov 07, 2022
Maintaining wellness while pursuing your Doctor of Pharmacy degree can be challenging. To address this, Student Societies of Health-System Pharmacists (SSHPs) are actively promoting wellbeing and resilience within their chapters. Through this podcast, we hope to highlight examples of how to incorporate wellness and wellbeing into SSHP initiatives, as well as share some tips on how to foster and sustain well-being and resilience during pharmacy school.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Saturday Nov 05, 2022
Saturday Nov 05, 2022
The opioid epidemic is a dynamic multi-layered situation with regulatory changes affecting patients and providers in a variety of ways. Although many regulation changes were designed with the best intentions, unintended consequences have surfaced in acute pain management for pediatric patients. This podcast will discuss some of the implications and safety issues while providing information regarding appropriate pediatric medication therapy.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Thursday Nov 03, 2022
Thursday Nov 03, 2022
This episode features highlights from the 2021 Midyear Clinical Meeting where content matter experts from the Clinical Specialists and Scientists review the pharmacokinetic and pharmacdynamic characteristics a pharmacist must take into consideration when designing.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Wednesday Nov 02, 2022
Wednesday Nov 02, 2022
This session from the 2021 Midyear Clinical Meeting compares the advantages and disadvantages of continuing buprenorphine for opioid use disorder in patients with acute patients.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Tuesday Nov 01, 2022
Tuesday Nov 01, 2022
USP recently published final revisions to the nonsterile compounding chapter <795> and the sterile compounding chapter <797>. ASHP Senior Director of Pharmacy Practice and Quality Michael Ganio discusses the revisions, what to expect before the chapters become official, and implications for chapter <800> with compounding expert Patti Kienle.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Monday Oct 31, 2022
Monday Oct 31, 2022
This podcast focuses on lessons learned from two PGY-1 pharmacists who have both matched to a PGY-2 program. Speakers will discuss how they decided to pursue a PGY-1, how the process differs from the PGY-1 application/interview process, and ultimately how they decided where they wanted to go. This Podcast episode will help future PGY1 residents prepare for the process of identifying and applying to PGY-2 programs.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Friday Oct 28, 2022
Friday Oct 28, 2022
Faculty from our Summer Meeting symposium on COVID-19 in the immunocompromised population discuss new information and recommendation updates that have occurred since their initial presentation.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Thursday Oct 27, 2022
Thursday Oct 27, 2022
In this feature from the 2021 Midyear Clinical Meeting, our content matter experts share updates from the REDUCE-IT and STRENGTH trials and the role current therapies, as well as new and emerging therapies, play in managing dyslipidemia.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Wednesday Oct 26, 2022
Wednesday Oct 26, 2022
Tom Kraus and Nick Gentile will be discussing the current state of ASHP’s advocacy priorities since our members went to Capitol Hill in mid-September. They will be discussing federal provider status, protecting the 340B program, the elimination of the X waiver, and residency funding audits.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Tuesday Oct 25, 2022
Tuesday Oct 25, 2022
In this presentation from the 2021 Midyear Clinical Meeting, our content matter experts will share their recommendations on how to design strategies for diversity, equity and inclusion as a part of personnel recruitment, develop initiatives that support a culture of DEI within your department, share ways to engage all pharmacy staff in self-development and self-awareness surrounding DEI and create policies and procedures that create sustainable integration and advancement of DEI.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.